RenBio, Inc. — Form D
RenBio, Inc. of Long Island City, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-09-06. The offering totals $6.0M, of which $5.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-09-06
- Form: D
- Accession: 0000929638-24-003098
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $5.3M
- Remaining: $750K
- Investors: 7
- Date of first sale: 2024-08-22
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-523398
Issuer
- Name: RenBio, Inc.
- CIK: 0001840723
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 30-02 48th Avenue, Long Island City, NY, 11101
- Phone: (646) 440-9411
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Jaap A Goudsmit, M.D., Ph.D. | Director | Long Island City, NY |
| Zhi A Hong, Ph.D. | Director | Long Island City, NY |
| Rachel A Liberatore, Ph.D. | Director | Long Island City, NY |
| Donald A Tang | Director | Long Island City, NY |
| Walter A Wang, Sr. | Director | Long Island City, NY |
| Rachel A Liberatore, Ph.D. | Executive Officer | Long Island City, NY |
| Annelyn A O'Rourke | Executive Officer | Long Island City, NY |
| Neal Padte | Director | New York, NY |
| Neal Padte | Executive Officer | New York, NY |
| Chi-Chuan Chen | Director | New York, NY |
| David Chu | Director | New York, NY |
| Tamon Tseng | Director | New York, NY |
| Wan Feng Ting | Director | New York, NY |
Other filings by this issuer (1)
More